Rang	Name	Position
1	Mr. Kyle W. Gano Ph.D.	President, CEO & Director
2	Mr. Matthew C. Abernethy CPA	Chief Financial Officer
3	Dr. Jude Onyia Ph.D.	Chief Scientific Officer
4	Mr. Eric S. Benevich	Chief Commercial Officer
5	Dr. Eiry Wyn Roberts M.D.	Chief Medical Officer
6	Dr. Wylie W. Vale Ph.D.	Co-Founder
7	Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder of Neurocrine
8	Mr. Aaron Vosburgh	Senior Vice President of Finance & Accounting
9	Mr. Lewis Choi	Chief Information Officer
10	Mr. Todd Tushla	Vice President of Investor Relations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	13,49%	2,00 Mrd. USD
2	JPMorgan Chase & Co	6,29%	0,93 Mrd. USD
3	Dodge & Cox	5,49%	0,81 Mrd. USD
4	Vanguard Portfolio Management, LLC	4,89%	0,72 Mrd. USD
5	Vanguard Capital Management, LLC	4,47%	0,66 Mrd. USD
6	State Street Corp	4,31%	0,64 Mrd. USD
7	AQR Capital Management LLC	3,76%	0,56 Mrd. USD
8	Renaissance Technologies Corp	2,30%	0,34 Mrd. USD
9	Geode Capital Management, LLC	2,10%	0,31 Mrd. USD
10	Two Sigma Investments LLC	2,04%	0,30 Mrd. USD
11	Vestal Point Capital LP	1,85%	0,27 Mrd. USD
12	BNP Paribas Investment Partners SA	1,47%	0,22 Mrd. USD
13	Morgan Stanley - Brokerage Accounts	1,30%	0,19 Mrd. USD
14	RTW INVESTMENTS, LLC	1,25%	0,19 Mrd. USD
15	Northern Trust Corp	1,24%	0,18 Mrd. USD
16	Amvescap Plc.	1,06%	0,16 Mrd. USD
17	Charles Schwab Investment Management Inc	0,96%	0,14 Mrd. USD
18	NORGES BANK	0,96%	0,14 Mrd. USD
19	First Trust Advisors L.P.	0,91%	0,13 Mrd. USD
20	Dimensional Fund Advisors, Inc.	0,72%	0,11 Mrd. USD